- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01261988
Assess the Safety and Adhesive Performance of the VIPER System When Compared to Esteem™
December 16, 2010 updated by: ConvaTec Inc.
A Single Center, Feasibility Study Using Healthy Volunteers to Assess the Safety and Adhesive Performance of the VIPER System When Compared to the Esteem™ Cut to Fit One Piece Closed End Pouch
The primary objective of the study is to assess the safety and adhesive performance of the VIPER System when compared to the Esteem™ Cut to Fit One Piece Closed End Pouch when used by healthy volunteers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Jobstown, New Jersey, United States, 08041
- Susan Bell, RN, MSN, CWOCN
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female between 18 and 70 years of age (inclusive) at the time of randomization
- Willing and able to provide written informed consent and HIPAA Waiver
- An appropriate candidate for participation with unbroken non-irritated abdominal skin
- Willing to adhere to the study procedures and to attend the scheduled study visits according to the requirements of the study protocol
- Willing to adhere to the scheduled study visits
- Good manual dexterity and be able to take care of their abdominal area independently
- Be willing and able to record the required study data in a specified format
Exclusion Criteria:
- A history of a known sensitivity or allergy to System 3+ adhesive (modified Stomahesive® technology), Stomahesive®, Durahesive®, Polyethylene Film, or polyester fiber,or to any adhesive components in general as listed in the Investigators Brochure.
- Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study
- Subjects with any chronic allergies requiring the use of prescription medication
- History of skin disease affecting abdominal area
- Currently uses topical ointments in the area of the abdomen or is unwilling/unable to terminate over the counter use of topical ointments in the area of the abdomen
- Active case of eczema, dermatitis, psoriasis
- Pregnant or lactating females.
- Subject currently enrolled in another investigational study
- Possesses extensive knowledge about either product (ie employees that re members or extended members of the Core Team work in ostomy research and development, or ostomy division sales and marketing )
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety: Related Events
Time Frame: 17 hours
|
All adverse events (AE's) related to the use of the device
|
17 hours
|
|
Efficacy: Device Fall-Offs
Time Frame: 17 hours
|
The number and percentage of subjects with study device fall-off during the study
|
17 hours
|
|
Efficacy: Device Fall-Offs
Time Frame: 17 hours
|
The total number of study device fall-offs during the course of the study
|
17 hours
|
|
Safety: Skin Reactions
Time Frame: 17 hours
|
17 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adhesive
Time Frame: 1 hour
|
Initial tack of the adhesive (during first hour of wear)
|
1 hour
|
|
Ease of Removal
Time Frame: 17 hours
|
Ease of removal of the adhesive wafer from the skin
|
17 hours
|
|
Security
Time Frame: 17 hours
|
Perceived security of the study pouch during wear
|
17 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Qing Li, PhD, ConvaTec Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
December 15, 2010
First Submitted That Met QC Criteria
December 15, 2010
First Posted (Estimate)
December 17, 2010
Study Record Updates
Last Update Posted (Estimate)
December 20, 2010
Last Update Submitted That Met QC Criteria
December 16, 2010
Last Verified
December 1, 2010
More Information
Terms related to this study
Other Study ID Numbers
- CC-0512-10-A723
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.